NEW YORK ( TheStreet) -- Ardea Biosciences (Nasdaq: RDEA) hit a new 52-week low Monday as it is currently trading at $16.95, below its previous 52-week low of $18.11 with 14,531 shares traded as of 9:54 a.m. ET. Average volume has been 127,000 shares over the past 30 days. Ardea has a market cap of $536 million and is part of the health care sector and drugs industry. Shares are down 29.9% year to date as of the close of trading on Friday. Ardea Biosciences, Inc., a biotechnology company, focuses on the discovery and development of small-molecule therapeutics for the treatment of gout and cancer in the United States.
- Practice your RDEA trading strategies and win cash in our stock game.